Compare CDMOs with pharmaceutical packaging and labeling capabilities including blister packaging, bottling, serialization, and clinical trial labeling.
494 companies listed
Packaging and labeling is the final manufacturing step before distribution. Primary packaging (blisters, bottles, vials, pouches) directly contacts or contains the product. Secondary packaging (cartons, inserts, cases) provides information and protection. Both must comply with regulatory requirements for labeling content, child resistance, and serialization/track-and-trace.
Serialization is now mandatory in most major markets. The Drug Supply Chain Security Act (DSCSA) in the US, EU Falsified Medicines Directive (FMD), and similar regulations globally require unique serial numbers on each unit, enabling track-and-trace through the distribution chain. CDMOs must have validated serialization lines integrated with their packaging operations.
United States
UPM Pharmaceuticals is a U.S.-based CDMO specializing in late-stage commercial manufacturing of semi-solid and oral solid dose products. Operating from a 475,000 sq ft cGMP FDA-registered facility in Bristol, Tennessee, UPM is a family-owned company with 30+ years of experience. They handle DEA-controlled substances and provide services from technology transfer and scale-up through commercial manufacturing. Capabilities include formulation development, analytical development, coated tablet manufacturing, pharmaceutical serialization, aggregation, and full packaging and warehousing.
Germany
Vetter Pharma is a leading global Contract Development and Manufacturing Organization specializing in aseptic fill-and-finish services for injectable drug products. Headquartered in Ravensburg, Germany, Vetter operates as an independent, family-owned business with over 75 years of experience.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.